Total Payments
$9,305
2024 Payments
$999.49
Companies
33
Transactions
558
Medicare Patients
2,327
Medicare Billing
$249,895
Payment Breakdown by Category
Food & Beverage$9,224 (99.1%)
Education$52.77 (0.6%)
Gifts$27.45 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,224 | 553 | 99.1% |
| Education | $52.77 | 3 | 0.6% |
| Gift | $27.45 | 2 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,764 | 159 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,582 | 110 | $0 (2024) |
| PFIZER INC. | $1,391 | 90 | $0 (2023) |
| Janssen Biotech, Inc. | $584.72 | 30 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $537.75 | 34 | $0 (2023) |
| Celgene Corporation | $467.18 | 30 | $0 (2024) |
| UCB, Inc. | $268.32 | 14 | $0 (2020) |
| Valeant Pharmaceuticals North America LLC | $230.13 | 14 | $0 (2017) |
| Gilead Sciences, Inc. | $165.42 | 7 | $0 (2024) |
| Takeda Pharmaceuticals America, Inc. | $136.20 | 10 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $999.49 | 34 | Janssen Biotech, Inc. ($255.86) |
| 2023 | $1,466 | 91 | AbbVie Inc. ($435.13) |
| 2022 | $1,496 | 95 | ABBVIE INC. ($508.32) |
| 2021 | $987.28 | 56 | AbbVie Inc. ($286.79) |
| 2020 | $802.39 | 46 | AbbVie Inc. ($363.40) |
| 2019 | $1,278 | 85 | PFIZER INC. ($445.00) |
| 2018 | $1,151 | 75 | Takeda Pharmaceuticals U.S.A., Inc. ($257.82) |
| 2017 | $1,125 | 76 | AbbVie, Inc. ($281.81) |
All Payment Transactions
558 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $11.45 | General |
| Category: Immunology | ||||||
| 11/21/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $12.65 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Immunology | ||||||
| 10/31/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: LIVER DISEASE | ||||||
| 10/09/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $12.65 | General |
| Category: IMMUNOLOGY | ||||||
| 09/25/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/19/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $101.08 | General |
| Category: General - Biliary Devices_ENDO | ||||||
| 08/21/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/21/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $3.88 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/19/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: Immunology | ||||||
| 08/14/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: IMMUNOLOGY | ||||||
| 08/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $24.68 | General |
| Category: INTERNAL MEDICINE | ||||||
| 07/22/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: IMMUNOLOGY | ||||||
| 07/18/2024 | Janssen Scientific Affairs, LLC | STELARA (Biological) | Food and Beverage | In-kind items and services | $82.30 | General |
| Category: Immunology | ||||||
| 07/17/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $31.01 | General |
| Category: Immunology | ||||||
| 07/15/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $25.16 | General |
| Category: INTERNAL MEDICINE | ||||||
| 06/17/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: IMMUNOLOGY | ||||||
| 06/12/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Immunology | ||||||
| 06/04/2024 | ERBE USA INC | VIO3 (Device) | Food and Beverage | Cash or cash equivalent | $50.00 | General |
| Category: Gastroenterology | ||||||
| 05/28/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $27.21 | General |
| Category: IMMUNOLOGY | ||||||
| 05/14/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $77.94 | General |
| Category: IMMUNOLOGY | ||||||
| 04/29/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ, HUMIRA | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: IMMUNOLOGY | ||||||
| 04/24/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: INTERNAL MEDICINE | ||||||
| 04/23/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $30.49 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 491 | 516 | $269,298 | $54,479 |
| 2022 | 12 | 485 | 506 | $247,955 | $51,873 |
| 2021 | 11 | 701 | 745 | $342,088 | $74,068 |
| 2020 | 13 | 650 | 689 | $322,316 | $69,475 |
Total Patients
2,327
Total Services
2,456
Medicare Billing
$249,895
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 94 | 94 | $90,992 | $18,918 | 20.8% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 61 | 61 | $38,979 | $10,848 | 27.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 84 | 85 | $55,675 | $6,785 | 12.2% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 30 | 30 | $19,170 | $5,324 | 27.8% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 23 | 23 | $14,720 | $2,987 | 20.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 23 | 25 | $19,500 | $2,477 | 12.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 44 | 54 | $6,480 | $2,443 | 37.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $5,400 | $2,198 | 40.7% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 20 | 21 | $10,836 | $1,646 | 15.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $2,090 | $515.60 | 24.7% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2023 | 77 | 88 | $5,456 | $337.38 | 6.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 66 | 66 | $63,888 | $12,874 | 20.2% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 46 | 46 | $29,394 | $8,334 | 28.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 102 | 104 | $68,120 | $8,132 | 11.9% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 35 | 35 | $22,365 | $6,387 | 28.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 64 | 80 | $9,600 | $3,639 | 37.9% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 21 | 21 | $13,440 | $2,748 | 20.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 17 | 18 | $14,040 | $2,688 | 19.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 25 | 25 | $5,625 | $2,569 | 45.7% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 21 | 21 | $10,836 | $1,759 | 16.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 24 | 24 | $4,560 | $1,420 | 31.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 13 | 15 | $2,925 | $1,123 | 38.4% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2022 | 51 | 51 | $3,162 | $199.77 | 6.3% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 79 | 81 | $78,408 | $15,845 | 20.2% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2021 | 69 | 69 | $44,091 | $12,538 | 28.4% |
About Dr. David Scott, M.D
Dr. David Scott, M.D is a Gastroenterology healthcare provider based in Shreveport, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/27/2005. The National Provider Identifier (NPI) number assigned to this provider is 1760478465.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Scott, M.D has received a total of $9,305 in payments from pharmaceutical and medical device companies, with $999.49 received in 2024. These payments were reported across 558 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($9,224).
As a Medicare-enrolled provider, Scott has provided services to 2,327 Medicare beneficiaries, totaling 2,456 services with total Medicare billing of $249,895. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Shreveport, LA
- Active Since 09/27/2005
- Last Updated 08/29/2019
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1760478465
Products in Payments
- XELJANZ (Drug) $1,261
- ENTYVIO (Biological) $1,103
- HUMIRA (Biological) $669.16
- Humira (Biological) $623.58
- RINVOQ (Biological) $497.16
- STELARA (Biological) $492.92
- XIFAXAN (Drug) $479.72
- ZEPOSIA (Drug) $467.18
- SKYRIZI (Biological) $376.62
- Entyvio (Biological) $305.83
- Cimzia (Drug) $268.32
- Dexilant (Drug) $229.69
- LINZESS (Drug) $198.14
- TREMFYA (Drug) $174.10
- INFLECTRA (Biological) $109.91
- VIBERZI (Drug) $104.14
- CREON (Drug) $97.22
- UCERIS (Drug) $91.84
- Trulance (Drug) $90.86
- CLENPIQ (Drug) $85.71
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Shreveport
David Dies, M.d, M.D
Gastroenterology — Payments: $246,940
Gastroenterology $246,940
Sathya Jaganmohan, M.d, M.D
Gastroenterology — Payments: $65,914
Gastroenterology $65,914
John Provenza, M.d, M.D
Gastroenterology — Payments: $10,336
Gastroenterology $10,336
Dr. John Kirkikis, Md, MD
Gastroenterology — Payments: $6,909
Gastroenterology $6,909
Paul Jordan, M.d, M.D
Gastroenterology — Payments: $4,896
Gastroenterology $4,896
James Hobley, M.d, M.D
Gastroenterology — Payments: $4,422
Gastroenterology $4,422